Silicon Investor (SI) -- The First Internet Community

STOCKTALK

POLITICS
PASTIMES

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: CuttingEdge Bio who wrote (3001)	6/23/2020 2:31:41 PM
From: Miljenko Zuanic	1 Recommendation Recommended By CuttingEdge Bio Read Replies (2) \| Respond to of 3557

It is single infusion (~10-50 mg/Kg combine, depend on mode), so $2-4K/dose is more than DESIRABLE! Most likely it will be $<1K/dose, IMO. 100K doses/month is $100M/month, plenty to generate yearly profit. IF GOV & BARDA want higher level, let them manufacture drug itself!